Home > Professionals > Maligne hematologie > Lymfoïde ziekten > Plasmaceldyscrasieën > Multipel myeloom > Trispecific Antibody (79635322MMY1001)

Trispecific Antibody (79635322MMY1001)

Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis https://onderzoekmetmensen.nl/en/trial/53500

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 13-1-2026, 22:07